The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update.

Ramsey, L B

The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update. [electronic resource] - Clinical pharmacology and therapeutics Oct 2014 - 423-8 p. digital

Publication Type: Journal Article; Practice Guideline; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

1532-6535

10.1038/clpt.2014.125 doi


Drug Interactions
Genotype
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--adverse effects
Liver-Specific Organic Anion Transporter 1
Muscular Diseases--chemically induced
Organic Anion Transporters--genetics
Pharmacogenetics
Polymorphism, Genetic
Simvastatin--adverse effects